PROJECTS & INITIATIVES
Value of Treatment Publications
All published documents can now be read:
Discussion Paper 1
Discussion Paper 2
Policy white paper
Throughout the project, case study analyses have been conducted for the following disorders. Follow the individual links below to read more about each case study, and study the results of each disorder.
Normal-pressure hydrocephalus (NPH)
Restless Legs Syndrome
Full poster booklet
The Value of Treatment (VoT) project is supported through financial contributions from:
Biogen, BMS-Pfizer Alliance, Boehringer Ingelheim GmbH, Grunenthal, Janssen, Livanova, Lundbeck, Medtronic, MSD, Novartis, Pfizer, Roche, Takeda, TEVA Pharmaceuticals, UCB Biopharma, Vifor Pharma, EARLS and EURLSSG.